comparemela.com
7
8
9
10
11
12
13
Latest Breaking News On - Carsgen therapeutics holdings - Page 6 : comparemela.com
CARsgen Therapeutics Presents Updated Data for CT041 Claudin18.2 CAR T-cells in Solid Tumors at ASCO 2022
SHANGHAI, June 6, 2022 /PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell the.
China
Shanghai
United-states
Canada
Chinese
America
American
Raffaele-baffa
Zonghai-li
American-society-of-clinical-oncology
Carsgen-therapeutics-holdings
Prnewswire-carsgen-therapeutics-holdings-limited-stock-code
Nature Medicine Publishes Results from an Investigator-Initiated Trial of CARsgen's CT041 Claudin18.2 CAR T Cells in Gastrointestinal Cancers
SHANGHAI, May 10, 2022 /PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell the.
China
Beijing
Shanghai
United-states
Canada
Lin-shen
Guangdong
America
Zonghai-li
Carsgen-therapeutics-holdings
Prnewswire-carsgen-therapeutics-holdings-limited-stock-code
Health-canada
CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer
/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of.
Italy
United-states
America
Raffaele-baffa
Zonghai-li
School-of-medicine
Carsgen-therapeutics-holdings
University-of-parma
University-of-padova
Chief-executive-officer
Chief-scientific-officer
Therapeutics-holdings-limited
CARsgen Announces First Patient Enrollment in the Confirmatory Phase II Clinical Trial of CT041 in China
/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of.
Canada
China
United-states
America
Carsgen-therapeutics-holdings
Health-canada
Orphan-drug
Orphan-medicinal-product
Regenerative-medicine-advanced-therapy
North-america
Therapeutics-holdings
CARsgen 2021 Annual Results: Steady Advancement in Innovative CAR T Products and Technologies
/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of.
China
Japan
Shanghai
United-states
North-carolina
Research-triangle-park
Jinshan
Sichuan
Xuhui
South-korea
Republic-of-korea
America
vimarsana © 2020. All Rights Reserved.